Procter & Gamble (PG) Form 4: 298 RSUs awarded to director Joseph Jimenez
Rhea-AI Filing Summary
Joseph Jimenez, a director of Procter & Gamble Co. (PG), was granted 298 restricted stock units (RSUs) on 09/09/2025. The award is reported as having a $0 per-share price because it is a restricted grant rather than an open-market purchase. After the grant (which includes dividend equivalents credited as RSUs), Mr. Jimenez beneficially owns 34,100.9784 shares in total. The RSUs were awarded under The Procter & Gamble 2019 Stock and Incentive Compensation Plan. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Jimenez on 09/10/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Director received a routine RSU award; appears to be standard board compensation with no unusual terms.
The 298 RSU grant to a director is consistent with typical equity-based director compensation designed to align interests with shareholders. Reporting the grant at $0 reflects its restricted nature rather than a market purchase. The inclusion of dividend equivalents as additional RSUs is a common feature that modestly increases the total beneficial ownership reported. There is no disclosure in this Form 4 of accelerated vesting, special transfer provisions, or related-party transactions that would raise governance concerns.
TL;DR: This is a routine, non-cash equity grant under the company's 2019 incentive plan; impact on dilution is minimal.
A grant of 298 RSUs to a director represents a modest incremental equity award relative to total outstanding shares for a large-cap issuer like PG. The RSUs and dividend equivalents increase the director's reported beneficial ownership to 34,100.9784 shares. Without vesting schedule details or grant-date valuation in this filing, the financial statement impact and retention incentives cannot be fully assessed from the Form 4 alone. No material compensation changes are disclosed here.